Comparing Intrathecal Morphine and Erector Spinae Plane Regional Anesthesia Against Intrathecal Morphine Alone for Post-Cesarean Section Pain
Overview
- Phase
- Phase 4
- Intervention
- erector spinae plane block (ESP)
- Conditions
- Post-operative Pain
- Sponsor
- University of Miami
- Enrollment
- 100
- Primary Endpoint
- post-operative opioid analgesic medication
- Status
- Suspended
- Last Updated
- last year
Overview
Brief Summary
The objective of the study is to optimize post-operative analgesia and improve patient satisfaction while reducing total opioid consumption after cesarean section
Investigators
Reine Zbeidy
Associate Professor of Clinical Anesthesiology
University of Miami
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Adults unable to consent
- •Individuals \<18 years of age at time of admission
- •Individuals taking anticoagulant medications
- •Significant co-morbid disease of pregnancy (including: gestational diabetes and significant abnormal placentation)
- •Pre-existing chronic pain or pain disorder diagnosis
- •Conversion from neuraxial to general anesthesia
- •Prisoners
Arms & Interventions
erector spinae plane block
participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
Intervention: erector spinae plane block (ESP)
erector spinae plane block
participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
Intervention: Duramorph
erector spinae plane block
participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
Intervention: Ropivacaine
erector spinae plane block
participants will be in this group for up to 9 months and receive erector spinae plane (ESP) block
Intervention: Bupivacaine Injection
standard of care
participants in this group will receive the standard of care treatment and will be in this group for up to 9 months.
Intervention: Duramorph
standard of care
participants in this group will receive the standard of care treatment and will be in this group for up to 9 months.
Intervention: Ropivacaine
standard of care
participants in this group will receive the standard of care treatment and will be in this group for up to 9 months.
Intervention: Bupivacaine Injection
Outcomes
Primary Outcomes
post-operative opioid analgesic medication
Time Frame: up to 24 hours
measurement (milligrams)
Secondary Outcomes
- change in post-operative pain medication by visual analog scale(baseline, up to 24 hours)
- number of minutes to first use of rescue medication(up to 24 hours)
- obstetric quality of recovery scale(up to 24 hours)